Decreasing prostate specific antigen value leading to the diagnosis of a pituitary adenoma

Intravesical sequential gemcitabine and docetaxel versus bacillus calmette-guerin (BCG) plus interferon in patients with recurrent non-muscle invasive bladder cancer following a single induction course of BCG.

Urologic oncology·2021

Multi-Institution Evaluation of Sequential Gemcitabine and Docetaxel as Rescue Therapy for Nonmuscle Invasive Bladder Cancer.

The Journal of urology·2019

Expectant long-term follow-up of patients with chronic urinary retention.

Neurourology and urodynamics·2018

Gleason Misclassification Rate Is Independent of Number of Biopsy Cores in Systematic Biopsy.

Urology·2016

Can testosterone therapy be offered to men on active surveillance for prostate cancer? Preliminary results.

Asian journal of andrology·2015

Low free testosterone levels predict disease reclassification in men with prostate cancer undergoing active surveillance.

BJU international·2014

Chemotherapy Versus Surgery for Stage IIA Nonseminomatous Germ Cell Tumor: A Comparative Cost Utility Analysis.

The Journal of urology·2026

Bladder Cancer Incidence in Patients with Microhematuria at the Veterans Health Administration.

The Journal of urology·2026

Age- and sex-specific prevalence of lower urinary tract symptoms and bowel dysfunction in children: Results from a National Survey.

The Journal of urology·2026

Clofazimine pharmacokinetics in novel rifampicin-resistant tuberculosis regimens: an analysis of the endTB and endTB-Q trials.

medRxiv : the preprint server for health sciences·2026

Brain metabolic and network profiles characterized by comorbid depressive symptoms and sleep disturbances in Parkinson's disease: an 18F-FDG PET study.

Frontiers in aging neuroscience·2026

Antibiotics modulate activity of mouse and human dorsal root ganglia neurons.

bioRxiv : the preprint server for biology·2026

Widespread detection of Polyethylene glycol reveals chronic human exposure through pharmaceutical drugs.

bioRxiv : the preprint server for biology·2026

Digital Handwriting Reveals Motor Impairment, Dopaminergic Response, and Progression in Parkinson's Disease.

Movement disorders clinical practice·2026

Dopamine-replacing gene therapy for Parkinson's disease: biochemical background and current clinical experience.

Expert opinion on biological therapy·2026

Related Experiment Videos

Decreasing prostate specific antigen value leading to the diagnosis of a pituitary adenoma

Related Concept Videos

Intravesical sequential gemcitabine and docetaxel versus bacillus calmette-guerin (BCG) plus interferon in patients with recurrent non-muscle invasive bladder cancer following a single induction course of BCG.

Multi-Institution Evaluation of Sequential Gemcitabine and Docetaxel as Rescue Therapy for Nonmuscle Invasive Bladder Cancer.

Expectant long-term follow-up of patients with chronic urinary retention.

Gleason Misclassification Rate Is Independent of Number of Biopsy Cores in Systematic Biopsy.

Can testosterone therapy be offered to men on active surveillance for prostate cancer? Preliminary results.

Low free testosterone levels predict disease reclassification in men with prostate cancer undergoing active surveillance.

Chemotherapy Versus Surgery for Stage IIA Nonseminomatous Germ Cell Tumor: A Comparative Cost Utility Analysis.

Bladder Cancer Incidence in Patients with Microhematuria at the Veterans Health Administration.

Age- and sex-specific prevalence of lower urinary tract symptoms and bowel dysfunction in children: Results from a National Survey.

Clofazimine pharmacokinetics in novel rifampicin-resistant tuberculosis regimens: an analysis of the endTB and endTB-Q trials.

Brain metabolic and network profiles characterized by comorbid depressive symptoms and sleep disturbances in Parkinson's disease: an 18F-FDG PET study.

Antibiotics modulate activity of mouse and human dorsal root ganglia neurons.

Widespread detection of Polyethylene glycol reveals chronic human exposure through pharmaceutical drugs.

Digital Handwriting Reveals Motor Impairment, Dopaminergic Response, and Progression in Parkinson's Disease.

Dopamine-replacing gene therapy for Parkinson's disease: biochemical background and current clinical experience.

Related Experiment Videos

Decreasing prostate specific antigen value leading to the diagnosis of a pituitary adenoma

Related Concept Videos

Related Articles